Twist Bioscience Corp (TWST)
41.21
+9.20
(+28.74%)
USD |
NASDAQ |
May 03, 16:00
41.18
-0.03
(-0.07%)
After-Hours: 20:00
Twist Bioscience Net Income (Quarterly): -45.49M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -45.49M |
December 31, 2023 | -43.01M |
September 30, 2023 | -46.24M |
June 30, 2023 | -57.40M |
March 31, 2023 | -59.16M |
December 31, 2022 | -41.82M |
September 30, 2022 | -51.12M |
June 30, 2022 | -60.52M |
March 31, 2022 | -60.67M |
December 31, 2021 | -45.56M |
September 30, 2021 | -41.24M |
June 30, 2021 | -40.04M |
March 31, 2021 | -37.92M |
December 31, 2020 | -32.90M |
Date | Value |
---|---|
September 30, 2020 | -24.32M |
June 30, 2020 | -28.21M |
March 31, 2020 | -31.77M |
December 31, 2019 | -55.64M |
September 30, 2019 | -31.18M |
June 30, 2019 | -27.92M |
March 31, 2019 | -25.93M |
December 31, 2018 | -22.64M |
September 30, 2018 | -19.80M |
June 30, 2018 | -17.62M |
March 31, 2018 | -16.87M |
December 31, 2017 | -16.94M |
September 30, 2017 | -17.01M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-60.67M
Minimum
Mar 2022
-24.32M
Maximum
Sep 2020
-43.11M
Average
-42.42M
Median
Net Income (Quarterly) Benchmarks
Tandem Diabetes Care Inc | -30.00M |
Perspective Therapeutics Inc | -24.68M |
Xtant Medical Holdings Inc | -4.303M |
Asensus Surgical Inc | -17.24M |
Catheter Precision Inc | -0.669M |
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | 75.30M |
Total Expenses (Quarterly) | 124.19M |
EPS Diluted (Quarterly) | -0.79 |
Enterprise Value | 2.106B |
Gross Profit Margin (Quarterly) | 41.01% |
Profit Margin (Quarterly) | -60.41% |
Earnings Yield | -8.15% |
Normalized Earnings Yield | -7.600 |